Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Changes in the management of patients with side effects from the treatment of hepatitis C].

Nederlands tijdschrift voor geneeskunde - 3 Mar 2007

Bezemer G, Schalm S W, van Gool A R, de Knegt R J

Abstract excerpt

Since hepatitis C can be treated more and more successfully, treatment should be considered in every patient. In some of the patients infected by viral genotype I, the duration of treatment can be shortened: 24 weeks instead of 48 weeks. Maintaining the optimal dosage of ribavirin and peginterfer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Depression
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Recombinant Proteins

Source

Identifiers

PMID: 17373393

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17373393-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Changes in the management of patients with side effects from the treatment of hepatitis C].PMID 17373393Read ↗

[The treatment of hepatitis C].Semantic proximity Read ↗

[Treatment of hepatitis C].Semantic proximity Read ↗

Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from RomaniaSemantic proximity Read ↗

[Difficult-to-treat patients with chronic hepatitis C].Semantic proximity Read ↗

[Treatment of hepatitis C in intravenous drug users].Semantic proximity Read ↗

[Aspects for long-term anti-viral therapy in treatment of chronic hepatitis B].Semantic proximity Read ↗

How to optimize HCV therapy in genotype 1 patients: management of side-effects.Semantic proximity Read ↗

Pharmacological management of adverse events during treatment of chronic viral hepatitis in three Ivorian university hospitals .Semantic proximity Read ↗

[Treatment of patients with chronic hepatitis C virus infection and normal transaminases].Semantic proximity Read ↗

[Treatment of patients with chronic hepatitis C who never had been treated].Semantic proximity Read ↗

[Treatment of chronic hepatitis C with pegylated alpha-interferons].Semantic proximity Read ↗

[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.